In Vitro Diagnostic Test Procurement During the COVID-19 Pandemic: Lessons Learnt and Recommendations

Butler, Luke

Abstract

This White Paper examines the procurement of in vitro diagnostics (“IVDs”), specifically, commonly used test kits during the COVID-19 pandemic. The research has been commissioned by the British In Vitro Diagnostic Association (“BIVDA”). The White Paper examines key areas which include how test kits were procured, technical validation for use and regulatory approval for placement on the market. It identifies what lessons can be learnt from this experience and makes a number of recommendations to improve future emergency preparedness and diagnostics procurement generally, supported by a sustainable diagnostics industry.

Citation

Butler, L. (2023). In Vitro Diagnostic Test Procurement During the COVID-19 Pandemic: Lessons Learnt and Recommendations. British In Vitro Diagnostic Association

• Report Type: Other
• Online Publication Date: May 9, 2023
• Publication Date: May 9, 2023
• Deposit Date: May 12, 2023
• Publicly Available Date: May 19, 2023
• Pages: 170
• Public URL: https://nottingham-repository.worktribe.com/output/20565448
• Publisher URL: https://dmscdn.vuelio.co.uk/publicitem/110e4dda-b65f-434f-96ce-611a8b56f191
• Additional Information: The White Paper is available for download (open access) on the University of Nottingham Press Release Page:; ; https://www.nottingham.ac.uk/news/questions-over-procurement-and-transparency-uk-covid-tests